Geron Corporation Competitors, Revenue, Alternatives and Pricing
Overview
Employee Data
- Geron Corporation has 205 Employees.
- Geron Corporation currently has 1 job openings.
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
Advertise Here | ||||||
#1 | $7M | 45 | 10% | N/A | - | N/A |
#2 | N/A | 205 | N/A | N/A | - | N/A |
#3 | $46.8M | 302 | 4% | N/A | - | N/A |
#4 | $22.3M | 144 | N/A | N/A | - | N/A |
#5 | $44.3M | 286 | N/A | N/A | - | N/A |
#6 | $101.2M | 653 | 46% | N/A | - | N/A |
#7 | $18.6M | 120 | N/A | N/A | - | N/A |
#8 | $23.3M | 150 | N/A | N/A | - | N/A |
#9 | $33.3M | 215 | 3% | N/A | - | N/A |
#10 | $28.7M | 185 | 8% | N/A | - | N/A |
What Is Geron Corporation?
Geron Corporation is a development stage biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for applications in oncology and regenerative medicine, and research tools for drug discovery. The Company's product development programs are based upon three patented core technologies: telomerase, human embryonic stem cells and nuclear transfer. The Company is working to develop anti-cancer therapies based on telomerase inhibitors, oncolytic (cancer-killing) viruses and telomerase vaccines. The Company also intends to continue to develop and commercialize products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring and screening.
keywords:N/A205
Number of Employees
N/A
Revenue (est)
1
Current Jobs
N/A
Employee Growth %
N/A
Total Funding
N/A
Valuation
N/A
Accelerator
N/A
Type
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding | Online Review | Pricing |
---|---|---|---|---|---|---|
#1 | $54.4M | 214 | N/A | N/A | - | N/A |
#2 | N/A | 217 | 41% | N/A | - | N/A |
#3 | $40M | 222 | N/A | N/A | 5/5 | N/A |
#4 | N/A | 224 | N/A | N/A | - | N/A |
#5 | N/A | 241 | 10% | N/A | - | N/A |